Microtest Diagnostics was spun out of London’s Imperial College in 2002, with a mission to provide automated multiplex in-vitro diagnostic tests in the areas of Allergy, Autoimmune, Influenza and Infectious Disease. Following more than 10 years of development and over USD $10 million in R&D investment, Microtest Diagnostics recently received the CE-mark for its instrument.

The company operates with a highly skilled team of trained professionals with expertise across numerous fields including product, software and hardware design, instrument and assay development, regulatory approvals and quality control.

Website: www.microtestdx.com